Company Profile

HBVtech
Profile last edited on: 1/28/2023      CAGE: 6WC76      UEI: WEXNYHY4EZB5

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2013
First Award
2020
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

13901 Lullaby Road
Germantown, MD 20874
   (240) 688-6697
   information@hbvtech.com
   www.hbvtech.com
Location: Single
Congr. District: 06
County: Montgomery

Public Profile

A research based company structured around HBV research and discovery, HBVtech is addressing breaking HBV cycles and to clearing chronic HBV infection.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NIH $299,868
Project Title: Development of a Novel HBV Drug
2021 1 NIH $300,000
Project Title: A New HBV Drug for Establishing Durable Antiviral Efficacy of HBV Treatment
2021 1 NIH $306,368
Project Title: Antiviral Drugs to Cure Chronic Hepatitis B Virus Infection

Key People / Management

  Yong-Yuan Zhang -- Founder and Chief Science Officer

Company News

There are no news available.